SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor

All categories
DBCAT005510Therapeutic category

A DrugBank category of 1 drug. 1 of them is approved.

Drugs

What you can answer from here — as of July 28, 2021

1DrugEach linked to its full drug card
Listed above
4Drug targetsEvery drug–target pair in the class, with bond type
Sign in
12Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
2Routes of administrationHow the drugs in this class are given
Sign in

Which targets do SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In